Drugs ban: Partial relief from HC for Wockhardt,Glaxo & Griffon

Drugs ban: Partial relief from HC for Wockhardt,Glaxo & Griffon

Delhi High Court today stayed the the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.

India drugmaker stocks exception in Asian rout

In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.

India drugmaker stocks exception in Asian rout

Continued strength in the dollar when the Federal Reserve raises interest rates will also boost their income. More than 40 percent of over-the-counter and generic prescription drugs sold in the United States come from India.

Sun, Wockhardt recall drugs from US market

Sun Pharma and Wockhardt have separately initiated voluntary recall of a number of drugs from the US market due to different reasons.

Wockhardt recalls over 50 lakh bottles of various drugs in US

Wockhardt is recalling over 50 lakh bottles of various drugs, used for treating ailments like high blood pressure and ulcer, in the US market due to deviations in current good manufacturing practice norms laid down by the American health regulator.

USFDA completes Nalagarh facility inspection: Wockhardt

Drug firm Wockhardt, which has been under the USFDA scanner, Thursday said that United States health regulator has completed inspection of its Nalagarh facility in Himachal Pradesh.

Wockhardt recalls over 1.62 lakh cartons of drugs in US

As per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.

Wockhardt surges 3% on USFDA nod to market pain-relieving drug

Wockhardt surges 3% on USFDA nod to market pain-relieving drug

Shares of drug firm Wockhardt rose by nearly 3 percent on Monday as the company received approval from the US health regulator to market its Oxycodone HCl liquid, used for treating chronic pain, in the American market.

Two drugs manufactured by Wockhardt recalled in the US

According to information on the US Food and Drug Administration (USFDA) website, 166 bottles of Captopril tablets of 50 mg strength are being recalled in the US.

Wockhardt hopeful of early resolution of USFDA row

The company has now increased its R&D spend and filed more ANDAs in the US and Britain for approvals.

USFDA completes Waluj facility inspection: Wockhardt

Drug firm Wockhardt, which has been under the USFDA's scanner, Wednesday said that the American health regulator has completed the inspection of its Waluj facility in Maharashtra.

Wockhardt recalls 93K bottles of Captopril tablets from US

Recall has been initiated as the tablets failed to meet tablet/capsule specifications given by the USFDA.

Wockhardt shares slump over 6% on recall of some drugs

After falling 11.2 percent to Rs 1,181 in intra-day trade on the BSE, shares of the company finally ended at Rs 1,243.35, down 6.52 percent.

Wockhardt recalls 13 drugs in US after FDA concerns

Pharmaceuticals major Wockhardt is recalling 13 drugs in the US, manufactured at its two units at Chikalthana and Waluj in Maharashtra, which were under import restrictions from the USFDA.

US FDA did not find issues with Wockhardt's Chikalthana plant

"The recent inspection at the Aurangabad L1-Chikalthana site was a follow-up inspection by the US FDA as an outcome of completion of good manufacturing practise (GMP) remediation submitted by Wockhardt in October 2014.

Wockhardt says FDA raises new concerns about Waluj plant

Shares in Wockhardt Ltd fell as much as 5.3 percent on Thursday after the drugmaker said the U.S. Food and Drug Administration had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.

Wockhardt drug discovery gets fast track approval by USFDA

This is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued here.

Wockhardt drug discovery gets fast track approval by USFDA

Wockhardt today said its new drug discovery programme in anti-infective research has received a major boost after two of its drugs, WCK 771 and WCK 2349, received the Qualified Infectious Disease Product (QIDP)status from the US FDA.

USFDA grants QIDP status to two Wockhardt drugs

Drug maker Wockhardt on Sunday said that two of its anti-infective drugs have received Qualified Infectious Disease Product (QIDP) status from the US health regulator.

Wockhardt Q1 net profit falls 94% on plant bans

Wockhardt shares fell 5 percent to Rs 674 on Nifty that was up 0.54 percent.